Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator
Bradley P. Knight, MDa,
Rajiva Goyal, MDa,
Frank Pelosi, MDa,
Matthew Flemming, MDa,
Laura Horwood, RNa,
Fred Morady, MD, FACCa and
S. Adam Strickberger, MD, FACCa
a Department of Internal Medicine, Division of Cardiology, University of Michigan Medical Center, Ann Arbor, Michigan, USA
View larger version (21K):
[in a new window]
|
Figure 1 Kaplan-Meier survival curves depicting freedom from appropriate defibrillator shocks for patients in the Syncope Group (solid line) compared to the Arrest Group (dotted line). Each vertical mark represents a censored event.
|
|
View larger version (19K):
[in a new window]
|
Figure 2 Kaplan-Meier survival curves depicting overall mortality for patients in the Syncope Group (solid line) compared to the Arrest Group (dotted line). Each vertical mark represents a censored event.
|
|
|
